Table 3.
p value | Odds ratio | 95% CI | ||
---|---|---|---|---|
MRI referral | noMRI | Reference | – | – |
Screening MRI | < 0.001 | 29.2 | 12.6–67.6 | |
Diagnostic MRI | 0.004 | 3.6 | 1.5–8.7 | |
Preoperative MRI | < 0.001 | 6.8 | 3.7–12.5 | |
Breast cancer risk | Familial breast cancer risk | 0.001 | 3.9 | 1.8–8.5 |
Hormonal status | Postmenopausal | Reference | – | – |
Premenopausal | 0.079 | 1.4 | 1.0–2.1 | |
Perimenopausal | 0.376 | 1.3 | 0.7–2.4 | |
Lesion features at US | No observable lesion | Reference | – | – |
Single focus | 0.140 | 1.5 | 0.9–2.7 | |
Multifocal | 0.010 | 2.5 | 1.2–5.0 | |
Multicentric | < 0.001 | 7.5 | 3.5–16.4 | |
Core-needle or vacuum-assisted biopsy | Lobular component | 0.001 | 2.1 | 1.4–3.3 |
CI, confidence interval; US, ultrasonography; MRI, magnetic resonance imaging